The research will be conducted under the auspices of the university's Tayside Innovation MedTech Ecosystem (TIME) team, which is analyzing differences in tissue characteristics.

PCCT technology allows for better visualization and segmentation of bone, blood clots, plaque, hemorrhages, and intracranial tumors at lower radiation doses, NeuroLogica said.